Video
Unknown · 0:00
Kevin Krauss, CEO of Aeropath (formerly focused solely on antibacterials, now expanding into inflammation/immunology), explains how his 20-year path from bench scientist to biotech strategist shapes his approach to dr...
Unknown · 0:00
Kevin Krauss, CEO of Aeropath (formerly focused solely on antibacterials, now expanding into inflammation/immunology), explains how his 20-year path from bench scientist to biotech strategist shapes his approach to dr...
Redirecting...